Logo image of MXL

MAXLINEAR INC (MXL) Stock Fundamental Analysis

USA - NASDAQ:MXL - US57776J1007 - Common Stock

16.45 USD
+0.25 (+1.54%)
Last: 10/3/2025, 4:50:22 PM
16.45 USD
0 (0%)
After Hours: 10/3/2025, 4:50:22 PM
Fundamental Rating

2

Overall MXL gets a fundamental rating of 2 out of 10. We evaluated MXL against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. MXL has a bad profitability rating. Also its financial health evaluation is rather negative. MXL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MXL had negative earnings in the past year.
In the past year MXL has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: MXL reported negative net income in multiple years.
MXL had a positive operating cash flow in 4 of the past 5 years.
MXL Yearly Net Income VS EBIT VS OCF VS FCFMXL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

MXL has a worse Return On Assets (-24.30%) than 82.14% of its industry peers.
With a Return On Equity value of -42.99%, MXL is not doing good in the industry: 83.04% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -24.3%
ROE -42.99%
ROIC N/A
ROA(3y)-8.18%
ROA(5y)-6.04%
ROE(3y)-13.22%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A
MXL Yearly ROA, ROE, ROICMXL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

MXL has a Gross Margin of 55.73%. This is in the better half of the industry: MXL outperforms 78.57% of its industry peers.
In the last couple of years the Gross Margin of MXL has remained more or less at the same level.
MXL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.93%
GM growth 5Y0.43%
MXL Yearly Profit, Operating, Gross MarginsMXL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

2

2. Health

2.1 Basic Checks

MXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
MXL has more shares outstanding than it did 1 year ago.
MXL has more shares outstanding than it did 5 years ago.
MXL has a worse debt/assets ratio than last year.
MXL Yearly Shares OutstandingMXL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MXL Yearly Total Debt VS Total AssetsMXL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

MXL has an Altman-Z score of 1.66. This is a bad value and indicates that MXL is not financially healthy and even has some risk of bankruptcy.
MXL's Altman-Z score of 1.66 is on the low side compared to the rest of the industry. MXL is outperformed by 70.54% of its industry peers.
MXL has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
MXL has a Debt to Equity ratio of 0.25. This is comparable to the rest of the industry: MXL outperforms 46.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 1.66
ROIC/WACCN/A
WACC11.45%
MXL Yearly LT Debt VS Equity VS FCFMXL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

MXL has a Current Ratio of 1.55. This is a normal value and indicates that MXL is financially healthy and should not expect problems in meeting its short term obligations.
MXL's Current ratio of 1.55 is on the low side compared to the rest of the industry. MXL is outperformed by 81.25% of its industry peers.
A Quick Ratio of 1.14 indicates that MXL should not have too much problems paying its short term obligations.
MXL has a worse Quick ratio (1.14) than 83.04% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.14
MXL Yearly Current Assets VS Current LiabilitesMXL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for MXL have decreased strongly by -11.63% in the last year.
MXL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.65%.
The Revenue has been growing slightly by 2.59% on average over the past years.
EPS 1Y (TTM)-11.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%108%
Revenue 1Y (TTM)-15.65%
Revenue growth 3Y-26.07%
Revenue growth 5Y2.59%
Sales Q2Q%18.29%

3.2 Future

MXL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.78% yearly.
Based on estimates for the next years, MXL will show a quite strong growth in Revenue. The Revenue will grow by 16.45% on average per year.
EPS Next Y129.3%
EPS Next 2Y69.45%
EPS Next 3Y48.24%
EPS Next 5Y35.78%
Revenue Next Year28.33%
Revenue Next 2Y22.89%
Revenue Next 3Y18.94%
Revenue Next 5Y16.45%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MXL Yearly Revenue VS EstimatesMXL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
MXL Yearly EPS VS EstimatesMXL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3 4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MXL. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 20.75, the valuation of MXL can be described as rather expensive.
Based on the Price/Forward Earnings ratio, MXL is valued a bit cheaper than 77.68% of the companies in the same industry.
MXL is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.32, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 20.75
MXL Price Earnings VS Forward Price EarningsMXL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MXL Per share dataMXL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

MXL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MXL's earnings are expected to grow with 48.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y69.45%
EPS Next 3Y48.24%

More info and screens

0

5. Dividend

5.1 Amount

MXL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAXLINEAR INC

NASDAQ:MXL (10/3/2025, 4:50:22 PM)

After market: 16.45 0 (0%)

16.45

+0.25 (+1.54%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)10-23 2025-10-23/amc
Inst Owners84.19%
Inst Owner Change0%
Ins Owners6.46%
Ins Owner Change-0.55%
Market Cap1.43B
Analysts72
Price Target20.25 (23.1%)
Short Float %6.86%
Short Ratio3.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.44%
Min EPS beat(2)-3.14%
Max EPS beat(2)10.01%
EPS beat(4)2
Avg EPS beat(4)6.63%
Min EPS beat(4)-10.24%
Max EPS beat(4)29.89%
EPS beat(8)4
Avg EPS beat(8)-1.98%
EPS beat(12)7
Avg EPS beat(12)-0.9%
EPS beat(16)11
Avg EPS beat(16)1.17%
Revenue beat(2)1
Avg Revenue beat(2)1.33%
Min Revenue beat(2)-0.01%
Max Revenue beat(2)2.67%
Revenue beat(4)3
Avg Revenue beat(4)1.18%
Min Revenue beat(4)-0.01%
Max Revenue beat(4)2.67%
Revenue beat(8)4
Avg Revenue beat(8)-1.03%
Revenue beat(12)4
Avg Revenue beat(12)-1.31%
Revenue beat(16)7
Avg Revenue beat(16)-0.89%
PT rev (1m)0%
PT rev (3m)31.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.71%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.75
P/S 3.79
P/FCF N/A
P/OCF N/A
P/B 2.93
P/tB 12.41
EV/EBITDA N/A
EPS(TTM)-0.48
EYN/A
EPS(NY)0.79
Fwd EY4.82%
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS4.34
BVpS5.61
TBVpS1.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.3%
ROE -42.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.73%
FCFM N/A
ROA(3y)-8.18%
ROA(5y)-6.04%
ROE(3y)-13.22%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.93%
GM growth 5Y0.43%
F-Score2
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 39.63%
Cap/Sales 4.85%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.14
Altman-Z 1.66
F-Score2
WACC11.45%
ROIC/WACCN/A
Cap/Depr(3y)51.53%
Cap/Depr(5y)53.82%
Cap/Sales(3y)5.32%
Cap/Sales(5y)5.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%108%
EPS Next Y129.3%
EPS Next 2Y69.45%
EPS Next 3Y48.24%
EPS Next 5Y35.78%
Revenue 1Y (TTM)-15.65%
Revenue growth 3Y-26.07%
Revenue growth 5Y2.59%
Sales Q2Q%18.29%
Revenue Next Year28.33%
Revenue Next 2Y22.89%
Revenue Next 3Y18.94%
Revenue Next 5Y16.45%
EBIT growth 1Y4.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year199.09%
EBIT Next 3Y62.18%
EBIT Next 5YN/A
FCF growth 1Y-154.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-129.18%
OCF growth 3YN/A
OCF growth 5YN/A